Salem, Ahmed Hamed
Dave, Nimita
Marbury, Thomas
Hu, Beibei
Miles, Dale
Agarwal, Suresh K.
Bueno, Orlando F.
Menon, Rajeev M.
Funding for this research was provided by:
AbbVie
Genentech
Article History
First Online: 5 April 2019
Compliance with Ethical Standards
:
: Ahmed Hamed Salem, Nimita Dave, Beibei Hu, Suresh K. Agarwal, Orlando F. Bueno, and Rajeev M. Menon are/were employees of AbbVie and may hold AbbVie stock or stock options. Thomas Marbury is an employee and equity owner of Orlando Clinical Research Center. Dale Miles is an employee of Genentech and may hold Genentech stock or stock options.
: Venetoclax is being developed in collaboration between AbbVie and Genentech/Roche. The study was sponsored by AbbVie and Genentech/Roche. AbbVie and Genentech/Roche contributed to the study design, research, and interpretation of data, and the writing, reviewing, and approving of the publication.